ESOPHAGEAL SQUAMOUS CELL CANCER
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink tough tumors
Disease control OngoingThis study is testing whether adding an experimental drug called futibatinib to standard immunotherapy and chemotherapy can better control advanced esophageal or pancreatic cancer. It is for adults who have not yet received treatment for their advanced cancer. The goal is to see …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CANCER
Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Apr 03, 2026 19:55 UTC
-
New drug trial targets Tough-to-Treat advanced cancers
Disease control ENROLLING_BY_INVITATIONThis early-stage study is testing a new drug called RNDO-564, both by itself and combined with an existing immunotherapy (pembrolizumab), in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe dose levels and see …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: Rondo Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC